A citation-based method for searching scientific literature

Anne-Laure Couderc, Emanuel Nicolas, Romain Boissier, Mohammed Boucekine, Cyrille Bastide, Delphine Badinand, Dominique Rossi, Benedicte Mugnier, Patrick Villani, Gilles Karsenty, Didier Cowen, Eric Lechevallier, Xavier Muracciole. Cancers (Basel) 2020
Times Cited: 4







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The cardiovascular effects of gonadotropin-releasing hormone antagonists in men with prostate cancer.
Filipe Cirne, Nazanin Aghel, Jo-Anne Petropoulos, Laurence Klotz, Daniel J Lenihan, Fred Saad, Jehonathan Pinthus, Darryl P Leong. Eur Heart J Cardiovasc Pharmacother 2022
6
50

Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer.
Lova Sun, Ravi B Parikh, Rebecca A Hubbard, John Cashy, Samuel U Takvorian, David J Vaughn, Kyle W Robinson, Vivek Narayan, Bonnie Ky. JAMA Netw Open 2021
4
50

Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review.
Rei Kamitani, Kazuhiro Matsumoto, Takeo Kosaka, Toshikazu Takeda, Akinori Hashiguchi, Nobuyuki Tanaka, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Hiroshi Asanuma,[...]. Clin Genitourin Cancer 2021
2
50

Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.
Satoru Taguchi, Kenshiro Shiraishi, Hiroshi Fukuhara, Keiichi Nakagawa, Teppei Morikawa, Akihiro Naito, Shigenori Kakutani, Yuta Takeshima, Hideyo Miyazaki, Tohru Nakagawa,[...]. Int J Clin Oncol 2016
11
25

Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up.
D E Spratt, W C Jackson, A Abugharib, S A Tomlins, R T Dess, P D Soni, J Y Lee, S G Zhao, A I Cole, Z S Zumsteg,[...]. Prostate Cancer Prostatic Dis 2016
35
25

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
Jonathan I Epstein, Michael J Zelefsky, Daniel D Sjoberg, Joel B Nelson, Lars Egevad, Cristina Magi-Galluzzi, Andrew J Vickers, Anil V Parwani, Victor E Reuter, Samson W Fine,[...]. Eur Urol 2016
727
25

Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.
Michael S Leapman, Janet E Cowan, Jeffry Simko, Gray Roberge, Bradley A Stohr, Peter R Carroll, Matthew R Cooperberg. Eur Urol 2017
30
25



Independent surgical validation of the new prostate cancer grade-grouping system.
Daniel E Spratt, Adam I Cole, Ganesh S Palapattu, Alon Z Weizer, William C Jackson, Jeffrey S Montgomery, Robert T Dess, Shuang G Zhao, Jae Y Lee, Angela Wu,[...]. BJU Int 2016
41
25

Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer.
Marco Moschini, Vidit Sharma, Matteo Soligo, Sarah Psutka, Laureano Rangel, Stephen A Boorjian, Igor Frank, Matthew T Gettman, R Houston Thompson, Matthew K Tollefson,[...]. Scand J Urol 2018
5
25


Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.
Stacy Loeb, Yasin Folkvaljon, David Robinson, Ingela Franck Lissbrant, Lars Egevad, Pär Stattin. Eur Urol 2016
88
25

Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis.
Yasutaka Yamada, Shinichi Sakamoto, Jun Shimazaki, Masahiro Sugiura, Yoshiyasu Amiya, Makoto Sasaki, Takayuki Shima, Akira Komiya, Noriyuki Suzuki, Koichiro Akakura,[...]. Prostate Int 2017
5
25

The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study.
Paolo Dell'Oglio, Robert Jeffrey Karnes, Giorgio Gandaglia, Nicola Fossati, Armando Stabile, Marco Moschini, Vito Cucchiara, Emanuele Zaffuto, Pierre I Karakiewicz, Nazareno Suardi,[...]. Prostate 2017
19
25

The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 Prostate Cancer.
Derya Tilki, Christoph Würnschimmel, Felix Preisser, Markus Graefen, Hartwig Huland, Philipp Mandel, Pierre Tennstedt. Eur Urol Focus 2020
3
33

Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens.
Keiichiro Mori, Vidit Sharma, Eva M Comperat, Shun Sato, Ekaterina Laukhtina, Victor M Schuettfort, Benjamin Pradere, Mehdi Kardoust Parizi, Pierre I Karakiewicz, Shin Egawa,[...]. Eur J Surg Oncol 2021
4
25

Gleason 5+4 has worse oncological and pathological outcomes compared with Gleason 4+5: significance of Gleason 5 pattern.
Sey Kiat Lim, Kwang Hyun Kim, Tae-Young Shin, Byung Ha Chung, Sung Joon Hong, Young Deuk Choi, Koon Ho Rha. Ann Surg Oncol 2013
19
25

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.
Phillip M Pierorazio, Patrick C Walsh, Alan W Partin, Jonathan I Epstein. BJU Int 2013
427
25

Predicting survival of men with recurrent prostate cancer after radical prostatectomy.
Paolo Dell'Oglio, Nazareno Suardi, Stephen A Boorjian, Nicola Fossati, Giorgio Gandaglia, Zhe Tian, Marco Moschini, Umberto Capitanio, Pierre I Karakiewicz, Francesco Montorsi,[...]. Eur J Cancer 2016
20
25


Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy.
Sophie Knipper, Pierre I Karakiewicz, Alexander Heinze, Felix Preisser, Thomas Steuber, Hartwig Huland, Markus Graefen, Derya Tilki. Urol Oncol 2020
7
25

Adjuvant Radiotherapy in Prostate Cancer Patients Treated with Surgery: The Impact of Age and Tumor Characteristics.
Firas Abdollah, Pierre I Karakiewicz, Giorgio Gandaglia, Deepansh Dalela, Dane E Klett, Jonas Shiffmann, Francesco Montorsi, Alberto Briganti, Fred Saad, Markus Graefen,[...]. Eur Urol Focus 2015
4
25

Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.
Greetta Hackman, Kimmo Taari, Teuvo L Tammela, Mika Matikainen, Mauri Kouri, Timo Joensuu, Tiina Luukkaala, Arto Salonen, Taina Isotalo, Anssi Pétas,[...]. Eur Urol 2019
39
25

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke, Claudia Bronner, Ursula Steiner, Alessandra Siegmann, Reinhard Golz, Stephan Störkel, Normann Willich, Axel Semjonow,[...]. Eur Urol 2014
262
25

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Paul Sargos, Sylvie Chabaud, Igor Latorzeff, Nicolas Magné, Ahmed Benyoucef, Stéphane Supiot, David Pasquier, Menouar Samir Abdiche, Olivier Gilliot, Pierre Graff-Cailleaud,[...]. Lancet Oncol 2020
77
25

A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.
Sophie Knipper, Angela Pecoraro, Carlotta Palumbo, Giuseppe Rosiello, Stefano Luzzago, Zhe Tian, Alberto Briganti, Fred Saad, Derya Tilki, Markus Graefen,[...]. Clin Genitourin Cancer 2019
9
25

Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer.
Emanuele Zaffuto, Giorgio Gandaglia, Nicola Fossati, Paolo Dell'Oglio, Marco Moschini, Vito Cucchiara, Nazareno Suardi, Vincenzo Mirone, Marco Bandini, Shahrokh F Shariat,[...]. J Urol 2017
42
25

Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
Alberto Briganti, Thomas Wiegel, Steven Joniau, Cesare Cozzarini, Marco Bianchi, Maxine Sun, Bertrand Tombal, Karin Haustermans, Tom Budiharto, Wolfgang Hinkelbein,[...]. Eur Urol 2012
127
25

Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancer.
Felix Preisser, Gilberto Coxilha, Alexander Heinze, Su Oh, Felix K-H Chun, Guido Sauter, Raisa S Pompe, Hartwig Huland, Markus Graefen, Derya Tilki. Prostate 2019
18
25

Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool.
Daniel M Frendl, Gordon FitzGerald, Mara M Epstein, Jeroan J Allison, Mitchell H Sokoloff, John E Ware. PLoS One 2020
3
33

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.
James M Wilson, David P Dearnaley, Isabel Syndikus, Vincent Khoo, Alison Birtle, David Bloomfield, Ananya Choudhury, John Graham, Catherine Ferguson, Zafar Malik,[...]. Int J Radiat Oncol Biol Phys 2018
23
25

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.
Ian M Thompson, Catherine M Tangen, Jorge Paradelo, M Scott Lucia, Gary Miller, Dean Troyer, Edward Messing, Jeffrey Forman, Joseph Chin, Gregory Swanson,[...]. J Urol 2009
901
25

Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact?
Hideya Yamazaki, Koji Masui, Gen Suzuki, Satoaki Nakamura, Norihiro Aibe, Daisuke Shimizu, Kei Yamada, Koji Okihara, Takumi Shiraishi, Tadayuki Kotsuma,[...]. J Clin Med 2019
6
25

Biochemical control after adjuvant radiation therapy for prostate cancer: a unicentric, retrospective analysis.
Alexandru-Teodor Zaharie, Matthias Moll, Gregor Goldner. Strahlenther Onkol 2021
1
100

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).
Michel Bolla, Hein van Poppel, Bertrand Tombal, Kris Vekemans, Luigi Da Pozzo, Theo M de Reijke, Antony Verbaeys, Jean-François Bosset, Roland van Velthoven, Marc Colombel,[...]. Lancet 2012
576
25

Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer.
Anastassia Löser, Burkhard Beyer, Cedric Oliver Carl, Benjamin Löser, Yamini Nagaraj, Thorsten Frenzel, Cordula Petersen, Andreas Krüll, Markus Graefen, Rudolf Schwarz. Strahlenther Onkol 2019
7
25

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Nicolas Mottet, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen,[...]. Eur Urol 2021
345
25

A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients.
Nikola Rakic, Akshay Sood, Deepansh Dalela, Sohrab Arora, Ulyana Malovana, Jacob Keeley, Craig Rogers, James Peabody, Mani Menon, Firas Abdollah. Clin Genitourin Cancer 2020
4
25

Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement.
Simona Dinicola, Gianmarco Fabrizi, Maria Grazia Masiello, Sara Proietti, Alessandro Palombo, Mirko Minini, Abdel Halim Harrath, Saleh H Alwasel, Giulia Ricci, Angela Catizone,[...]. Exp Cell Res 2016
28
25

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.
Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, Adrienne M Luoma, Yoshinaga Ito, Soumya Badrinath, Daphne Tsoucas, Bettina Franz, Kenneth F May, Christopher J Harvey,[...]. Science 2018
188
25

Tumor dissemination: an EMT affair.
Jean Paul Thiery, Chwee Teck Lim. Cancer Cell 2013
134
25

Circulating Tumor Cell Composition in Renal Cell Carcinoma.
Ivonne Nel, Thomas C Gauler, Kira Bublitz, Lazaros Lazaridis, André Goergens, Bernd Giebel, Martin Schuler, Andreas-Claudius Hoffmann. PLoS One 2016
29
25

Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.
Marie-Emilie Francart, Justine Lambert, Aline M Vanwynsberghe, Erik W Thompson, Morgane Bourcy, Myriam Polette, Christine Gilles. Dev Dyn 2018
68
25

In Vivo Enrichment and Elimination of Circulating Tumor Cells by Using a Black Phosphorus and Antibody Functionalized Intravenous Catheter.
Dou Wang, Chenchen Ge, Weiyuan Liang, Qinhe Yang, Quan Liu, Wei Ma, Lulin Shi, Hong Wu, Yuhua Zhang, Zongze Wu,[...]. Adv Sci (Weinh) 2020
9
25

Photodynamic inactivation of circulating tumor cells: An innovative approach against metastatic cancer.
Michael Raschpichler, Eduard Preis, Shashank Reddy Pinnapireddy, Elias Baghdan, Marcel Pourasghar, Marc Schneider, Udo Bakowsky. Eur J Pharm Biopharm 2020
5
25

Heterogeneous Manifestations of Epithelial-Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients.
Liubov A Tashireva, Olga E Savelieva, Evgeniya S Grigoryeva, Yuri V Nikitin, Evgeny V Denisov, Sergey V Vtorushin, Marina V Zavyalova, Nadezhda V Cherdyntseva, Vladimir M Perelmuter. Int J Mol Sci 2021
3
33

The TICONC (Ticagrelor-Oncology) Study: Implications of P2Y12 Inhibition for Metastasis and Cancer-Associated Thrombosis.
Joy R Wright, Meera Chauhan, Chirag Shah, Alistair Ring, Anne L Thomas, Alison H Goodall, David Adlam. JACC CardioOncol 2020
4
25


Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.
K J Luzzi, I C MacDonald, E E Schmidt, N Kerkvliet, V L Morris, A F Chambers, A C Groom. Am J Pathol 1998
800
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.